2-(4-(4-chlorophenoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 1599467-68-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-(4-chlorophenoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• 英文别名: 2-[4-(4-Chlorophenoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• CAS: 1599467-68-1
• 化学式: C₁₈H₂₀BClO₃
• 分子量: 330.619
• InChiKey: UJILKXGAVXCNBB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.43
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(4-(4-chlorophenoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 在 四(三苯基膦)钯 、 potassium acetate 、 potassium carbonate 、 bis(dibenzylideneacetone)-palladium⁽⁰⁾ 、 三环己基膦 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 30.0h， 生成 2-[4-[4-(9,9-Diphenylfluoren-4-yl)phenoxy]phenyl]-4,6-diphenyl-1,3,5-triazine
  参考文献：
  名称：

  Compound and organic light-emitting element comprising same

  摘要：

  The present specification relates to a compound and an organic light emitting device comprising the same.

  公开号：

  US11730009B2
• 作为产物：
  描述：

  4-溴苯酚 在 吡啶 、 palladium bis[bis(diphenylphosphino)ferrocene] dichloride 、 potassium acetate 、 copper diacetate 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 30.0h， 生成 2-(4-(4-chlorophenoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
  参考文献：
  名称：

  Discovery, Synthesis, and Optimization of Antimalarial 4(1H)-Quinolone-3-Diarylethers

  摘要：

  The historical antimalarial compound endochin served as a structural lead for optimization. Endochin-like quinolones (ELQ) were prepared by a novel chemical route and assessed for in vitro activity against multidrug resistant strains of Plasmodium falciparum and against malaria infections in mice. Here we describe the pathway to discovery of a potent class of orally active antimalarial 4(1H)-quinolone-3-diarylethers. The initial prototype, ELQ-233, exhibited low nanomolar IC50 values against all tested strains including clinical isolates harboring resistance to atovaquone. ELQ-271 represented the next critical step in the iterative optimization process, as it was stable to metabolism and highly effective in vivo. Continued analoging revealed that the substitution pattern on the benzenoid ring of the quinolone core significantly influenced reactivity with the host enzyme. This finding led to the rational design of highly selective ELQs with outstanding oral efficacy against murine malaria that is superior to established antimalarials chloroquine and atovaquone.

  DOI：

  10.1021/jm500147k

文献信息

• [EN] AMINOPYRIDAZINONE COMPOUNDS AS PROTEIN KINASE INHIBITORS<br/>[FR] COMPOSÉS AMINOPYRIDAZINONE À UTILISER EN TANT QU'INHIBITEURS DE PROTÉINES KINASES
  申请人：ETERNITY BIOSCIENCE INC

  公开号：WO2016007185A1

  公开（公告）日：2016-01-14

  The present disclosure provides a compound of formula (I) and the use thereof for the therapeutic treatment of human cancers including B-cell lymphoma and autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis.

  本公开提供了一种化合物的公式(I)，以及其在治疗人类癌症包括B细胞淋巴瘤和自身免疫性疾病如类风湿性关节炎、系统性红斑狼疮和多发性硬化症中的用途。